Daniel Bondeson to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Daniel Bondeson has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.154
-
Burslem GM, Schultz AR, Bondeson DP, Eide CA, Savage Stevens SL, Druker BJ, Crews CM. Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation. Cancer Res. 2019 09 15; 79(18):4744-4753.
Score: 0.154